Skip to main content
. 2018 Jul 11;67(11):1789–1796. doi: 10.1007/s00262-018-2205-1

Table 1.

Summary table of the different modes of action of prostanoid and nuclear receptors and their ligands in DCs

Receptor Ligand Immunogenic properties Tolerogenic properties
EP1-4 PGE2 Induction of CD80, CD86, CCR7 [18] and MMP-9 [17] Inhibition of IL-12p70 [22] and chemokine receptor expression [26], induction of IL-10 [15, 23]
RAR/RXR Retinoids Inhibition of IL-12 and increase of IL-10 [45], production of RA leading to the attraction of regulatory T cells [43, 44]
GR Corticosteroids Inhibits maturation and pro-inflammatory cytokine production, strong induction of IL-10 [50]
VDR VDR ligands Inhibits differentiation and maturation and stimulates Treg induction [39, 52]
PPARγ PPARγ ligands Induction of Th2 immunity [59] Induction of regulatory mucosal phenotype [57]
LXR LXR ligands Increases maturation [63], required for DC-migration in response to CCR7 ligands [65] Inhibits maturation [61, 62], inhibits CCR7-dependent migration [64]
Nurr1 Orchestrates expression of immunoregulatory genes [74]
NOR-1 Required for TLR-mediated DC maturation [76] Required for CCR7 dependent DC migration [73]